If we look back a year or two, we'll remember that this company bought out Renovis, which as I recall was trading around $6/ps at the time, and was as high as $12. They had an interesting developing pipeline, and no major setbacks; they simply got digested by Evotec and then pretty much vanished from the radar. I have been holding this stock for a long time (since well before the merger), and I think at $6 Evotec is just beginning to recover to a level where it ought to be trading. I am in the green a bit and plan to hold for the time being in the thought that this stock could hit $8-10 by summer. That, of course, assumes that the stock market overall does not plunge into the toilet again big time, in which case, I'd expect Evotec to fall back to the $3-4 range, as everything else dives with it.

Time will tell.